SNY vs. NVO
Compare and contrast key facts about Sanofi (SNY) and Novo Nordisk A/S (NVO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SNY or NVO.
Correlation
The correlation between SNY and NVO is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
SNY vs. NVO - Performance Comparison
Key characteristics
SNY:
-0.08
NVO:
-0.70
SNY:
0.05
NVO:
-0.80
SNY:
1.01
NVO:
0.89
SNY:
-0.08
NVO:
-0.55
SNY:
-0.18
NVO:
-1.48
SNY:
9.43%
NVO:
17.13%
SNY:
22.42%
NVO:
36.27%
SNY:
-46.65%
NVO:
-71.31%
SNY:
-13.31%
NVO:
-46.24%
Fundamentals
SNY:
$127.21B
NVO:
$352.92B
SNY:
$1.85
NVO:
$2.93
SNY:
27.43
NVO:
26.86
SNY:
0.90
NVO:
1.28
SNY:
$36.66B
NVO:
$204.72B
SNY:
$25.74B
NVO:
$173.22B
SNY:
$9.62B
NVO:
$108.42B
Returns By Period
In the year-to-date period, SNY achieves a 5.20% return, which is significantly higher than NVO's -8.52% return. Over the past 10 years, SNY has underperformed NVO with an annualized return of 4.41%, while NVO has yielded a comparatively higher 15.65% annualized return.
SNY
5.20%
7.93%
0.24%
-2.20%
2.86%
4.41%
NVO
-8.52%
-25.74%
-39.95%
-26.03%
22.75%
15.65%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
SNY vs. NVO — Risk-Adjusted Performance Rank
SNY
NVO
SNY vs. NVO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Sanofi (SNY) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
SNY vs. NVO - Dividend Comparison
SNY's dividend yield for the trailing twelve months is around 4.01%, more than NVO's 1.83% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SNY Sanofi | 4.01% | 4.22% | 3.83% | 4.22% | 3.80% | 3.61% | 3.46% | 4.29% | 3.67% | 4.03% | 3.79% | 4.19% |
NVO Novo Nordisk A/S | 1.83% | 1.68% | 1.00% | 1.20% | 1.34% | 1.86% | 2.14% | 2.47% | 2.12% | 3.93% | 1.31% | 1.96% |
Drawdowns
SNY vs. NVO - Drawdown Comparison
The maximum SNY drawdown since its inception was -46.65%, smaller than the maximum NVO drawdown of -71.31%. Use the drawdown chart below to compare losses from any high point for SNY and NVO. For additional features, visit the drawdowns tool.
Volatility
SNY vs. NVO - Volatility Comparison
The current volatility for Sanofi (SNY) is 9.05%, while Novo Nordisk A/S (NVO) has a volatility of 21.75%. This indicates that SNY experiences smaller price fluctuations and is considered to be less risky than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
SNY vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between Sanofi and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities